Inter-rater variability for the American Society of Anesthesiologists classification in patients undergoing hepato-pancreato-biliary surgery (MILESTONE-2): international survey among surgeons and anaesthesiologists
Simone Augustinus(Amsterdam Neuroscience), Marc G. Besselink(Amsterdam Neuroscience), Tobias Keck(Krankenhaus der Augustinerinnen), Giuseppe Natalini(Fondazione Poliambulanza Istituto Ospedaliero), Luca Aldrighetti(Vita-Salute San Raffaele University), Mohammad Abu Hilal(Casa di Cura Villa Garda), Jasper P. Sijberden(Fondazione Poliambulanza Istituto Ospedaliero), Bas Groot Koerkamp, Thomas Kander(Lund University), John A. Windsor(University of Auckland), Martin H. Smith(University of the Witwatersrand), Giuseppe Fusai(The Royal Free Hospital), Francisco Carlos Bonofiglio(Hospital Italiano de Buenos Aires), Shailesh V. Shrikhande(Homi Bhabha National Institute), Adnan Alseidi(University of California, San Francisco), Carla Nau(University of Lübeck), Bobby Tingstedt(Lund University), Michael Guertin(The Ohio State University Wexner Medical Center), Joris I. Erdmann(Amsterdam University Medical Centers), Eduardo de Santibáñes(Universidad de Buenos Aires), Attila Szíjártó(Semmelweis University), Timothy M. Pawlik(The Ohio State University), Markus W. Hollmann(Amsterdam University Medical Centers), Dominik Krzanicki(The Royal Free Hospital), Katia Donadello(Université Libre de Bruxelles), Kevin C. Conlon(Trinity College Dublin), Ronald L. Harter(The Ohio State University Wexner Medical Center), Matthanja Bieze(University of Toronto), Manuel Pardo(University of California, San Francisco), Roberto Salvia(University of Verona), Vandana Agarwal(Homi Bhabha National Institute), Maria Elena Franceschetti(Fondazione Poliambulanza Istituto Ospedaliero), Ho‐Jin Lee(Seoul National University Hospital), Cristina R. Ferrone(Brigham and Women's Hospital), Keith E. Lewis(Rutgers, The State University of New Jersey), Jin‐Young Jang(Seoul National University), Alice C. Wei(Université Paris Cité), Henry A. Pitt(Rutgers, The State University of New Jersey), Thilo Hackert(Universität Hamburg)
Cited by 7
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914